Idexx Laboratories IDXX Extended warranties and post contract support — Deferred Revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiability.
The official record: Idexx Laboratories’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Idexx Laboratories's extended warranties and post contract support — deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Idexx Laboratories's extended warranties and post contract support — deferred revenue?
- Idexx Laboratories (IDXX) reported extended warranties and post contract support — deferred revenue of $27.3M in Q1 2026.
- How has Idexx Laboratories's extended warranties and post contract support — deferred revenue changed year-over-year?
- Idexx Laboratories's extended warranties and post contract support — deferred revenue increased by 5.8% year-over-year, from $25.8M to $27.3M.
- What does extended warranties and post contract support — deferred revenue mean?
- This represents the total amount of consideration received from customers for extended warranties and post-contract support that has not yet been recognized as revenue. It reflects the company's liability to provide future services for which payment has already been collected. This balance is a key indicator of the company's future recurring revenue stream from its installed base of equipment.